Neoprobe Corporation to Present at Acumen BioFin Conference

DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that its President and Chief Executive Officer, David Bupp, will present on Wednesday, November 7, 2007 at 2:00 PM EST, in the Kennedy II Room, during the Acumen BioFin (Rodman & Renshaw) 9th Annual Healthcare Conference to be held at the New York Palace Hotel in New York, New York. Mr. Bupp’s presentation will provide an overview of the company’s technology and business strategy.

MORE ON THIS TOPIC